Skip to content
VuFind
Book Bag:
0
items
(Full)
Institutional Login
Language
English
Deutsch
All Fields
Title
Author
Subject
ISBN/ISSN
K10+-PPN
OCLC Number
Find
Advanced
Start
BCL-2 inhibition synergizes wi...
Cite this
Email this
Print
Export Record
Export to RefWorks
Export to EndNoteWeb
Export to EndNote
Export to RDF
Export to BibTeX
Export to RIS
Save to List
Permanent link
BCL-2 inhibition synergizes with dual targeting of FLT3 and AXL in FLT3 wildtype AML via downregulation of MCL-1
Saved in:
Bibliographic Details
Main Author:
Schmidt, Christina
(Author)
Format:
Book/Monograph
Thesis
Language:
English
Published:
Heidelberg
2023
Subjects:
Hochschulschrift
Online Access:
Author Notes:
vorgelegt von: Christina Schmidt ; Doktorvater: Herr Prof. Dr. med. Carsten Müller-Tidow
Description
Staff View
Description
Description not available.
Similar Items
Targeting FLT3 mutations in AML: review of current knowledge and evidence
by: Daver, Naval, et al.
Published: (2019)
Venetoclax synergizes with gilteritinib in FLT3 wild-type high-risk acute myeloid leukemia by suppressing MCL-1
by: Janssen, Maike, et al.
Published: (2022)
Palbociclib treatment of FLT3-ITD+ AML cells uncovers a kinase-dependent transcriptional regulation of FLT3 and PIM1 by CDK6
by: Uras, Iris Z., et al.
Published: (2016)
Midostaurin plus intensive chemotherapy for younger and older patients with AML and FLT3 internal tandem duplications
by: Döhner, Hartmut, et al.
Published: (2022)
Measurable residual disease monitoring in AML with FLT3-ITD treated with intensive chemotherapy plus midostaurin
by: Rücker, Frank Gert, et al.
Published: (2024)